Gyre Therapeutics
GYRE
GYRE
17 hedge funds and large institutions have $2.48M invested in Gyre Therapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
37% less funds holding
Funds holding: 27 → 17 (-10)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
17
Holding in Top 10
1
Calls
$1.51M
Puts
$337K
Top Buyers
| 1 | +$378K | |
| 2 | +$156K | |
| 3 | +$89K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$80K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.3K |
Top Sellers
| 1 | -$92.2K | |
| 2 | -$50K | |
| 3 | -$31K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$25K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$24K |